Outreach
Discover how ideas born at St. Jude reach well beyond the hospital walls, influencing STEMM education, global health and more.
Weaving palliative principles into sickle cell disease care
St. Jude clinicians collaborate with fellow palliative care experts to advocate for bringing palliative care to patients with sickle cell disease.
Collaborative science fuels innovation in immunotherapy effort to treat brain tumors
Learn about how an award-winning scientific collaboration is pushing forward novel cancer therapies.
Shaping a legacy of education and training at St. Jude
Meet Suzanne Gronemeyer, PhD, and discover how she built a legacy of education and training at St. Jude.
Master’s program helps launch data science careers at St. Jude
See how the St. Jude Graduate School of Biomedical Sciences trains students in the Applied Biomedical Data Science MS program.
Understanding critical pathways drives targeted therapy efforts
See how St. Jude scientists turn research into strategies for drugging key cancer pathways.
Studies link SMARCAL1 to increased risk for pediatric bone cancer
Two St. Jude efforts independently uncovered the predisposition gene’s role.
The behind-the-scenes chemistry driving drug discovery
See how St. Jude chemists approach drug discovery and development to make the therapies of tomorrow.
Solving the mysterious case of DICER1 cancer predisposition for pediatric rhabdomyosarcoma
Investigate the decades-long cold case that St. Jude researchers finally cracked.
The turbulent chemistry behind smarter, safer therapeutics
Explore the ingenuity behind therapeutic optimization
Reducing the risk of posterior fossa syndrome: Questions for Paul Klimo, MD
Neurosurgeon Paul Klimo, MD, explains posterior fossa syndrome, and how surgeons can work to reduce its risk.